CUBT
Price:
$1.3138
Market Cap:
$8.96M
Curative Biotechnology, Inc. is an emerging biomedical firm primarily focused on developing pharmaceutical products. Its research and development efforts are concentrated on a diverse pipeline targeting critical therapeutic areas, including infectious diseases, cancer, and vision-impairing degenerative eye conditions. Among its key pipeline assets is IMT504, an innovative immunotherapy designed for rabies treatment and as a vaccine enhancer. Another prominent candidate is CUBT906, a fully humanized CD56 monoclonal antibody that delivers a pyrrolobenzodiazepine dimer directly to tumor cells, aiming to eradicate them by halting their growth and spread. Additionally, the company is advancing a ...[Read more]
Industry
Biotechnology
IPO Date
1998-03-30
Stock Exchange
OTC
Ticker
CUBT
According to Curative Biotechnology, Inc.’s latest financial reports and current stock price. The company's current ROE is 41.35%. This represents a change of 295.31% compared to the average of 10.46% of the last 4 quarters.
The mean historical ROE of Curative Biotechnology, Inc. over the last ten years is -24.25%. The current 41.35% ROE has changed -270.54% with respect to the historical average. Over the past ten years (40 quarters), CUBT's ROE was at its highest in in the March 2020 quarter at 5.76%. The ROE was at its lowest in in the June 2021 quarter at -380.88%.
Average
-24.25%
Median
3.91%
Minimum
-317.51%
Maximum
211.95%
Discovering the peaks and valleys of Curative Biotechnology, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 212.41%
Maximum Annual ROE = 211.95%
Minimum Annual Increase = -2240.58%
Minimum Annual ROE = -317.51%
| Year | ROE | Change |
|---|---|---|
| 2025 | 37.18% | -48.76% |
| 2024 | 72.57% | -42.37% |
| 2023 | 125.91% | -40.59% |
| 2022 | 211.95% | -166.75% |
| 2021 | -317.51% | 9.40% |
| 2020 | -290.22% | 212.41% |
| 2019 | -92.90% | -2240.58% |
| 2018 | 4.34% | 24.51% |
| 2017 | 3.49% | 27.48% |
| 2016 | 2.73% | -108.87% |
The current ROE of Curative Biotechnology, Inc. (CUBT) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
78.55%
5-year avg
26.02%
10-year avg
-24.25%
Curative Biotechnology, Inc.’s ROE is less than Quantum Genomics S.A. (880.77%), greater than ProText Mobility, Inc. (0%), less than Chimeric Therapeutics Limited (2.84%), less than BetterLife Pharma Inc. (15.84%), less than Theralink Technologies, Inc. (147.47%), less than Mosaic ImmunoEngineering Inc. (9.22%), less than BioVaxys Technology Corp. (121.88%), greater than Glow Lifetech Corp. (-20.26%), greater than Futura Medical plc (-310.00%), less than NanoSphere Health Sciences Inc. (6.14%),
| Company | ROE | Market cap |
|---|---|---|
| 880.77% | $6.96M | |
| 0% | $10.71M | |
| 2.84% | $4.10M | |
| 15.84% | $7.77M | |
| 147.47% | $615.15K | |
| 9.22% | $4.88M | |
| 121.88% | $4.10M | |
| -20.26% | $6.13M | |
| -310.00% | $2.38M | |
| 6.14% | $98.64K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Curative Biotechnology, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Curative Biotechnology, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Curative Biotechnology, Inc.'s ROE?
How is the ROE calculated for Curative Biotechnology, Inc. (CUBT)?
What is the highest ROE for Curative Biotechnology, Inc. (CUBT)?
What is the 3-year average ROE for Curative Biotechnology, Inc. (CUBT)?
What is the 5-year average ROE for Curative Biotechnology, Inc. (CUBT)?
How does the current ROE for Curative Biotechnology, Inc. (CUBT) compare to its historical average?